Provided By GlobeNewswire
Last update: Oct 16, 2025
SAN ANTONIO, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, is pleased to announce that it will exhibit at the American Society for Reproductive Medicine (ASRM) 2025 Scientific Congress & Expo, which will take place October 25-29 at the Henry B. González Convention Center in San Antonio, Texas. The company will showcase its fertility solutions at booth #619.
Read more at globenewswire.com0.6013
-0.1 (-14.48%)
Find more stocks in the Stock Screener